{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dronabinol+2.5+MG&page=2", "query": { "intervention": "Dronabinol 2.5 MG", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 26, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dronabinol+2.5+MG&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Dronabinol+2.5+MG&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-30T09:55:46.542Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01361607", "title": "Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain", "Advanced Cancer" ], "interventions": [ { "name": "Nabiximols", "type": "DRUG" }, { "name": "Placebo (GA-0034)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 399, "start_date": "2011-05-27", "completion_date": "2014-11-24", "has_results": true, "last_update_posted_date": "2023-04-12", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 20, "location_summary": "Glendale, California • Santa Rosa, California • Clearwater, Florida + 16 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Holiday", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01361607" }, { "nct_id": "NCT00642499", "title": "Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting", "HIV Infections" ], "interventions": [ { "name": "Dronabinol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Solvay Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 103, "start_date": "2003-08", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2008-04-02", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 36, "location_summary": "Bakersfield, California • Fresno, California • Los Angeles, California + 27 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palm Springs", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00642499" }, { "nct_id": "NCT01262651", "title": "Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain", "Advanced Cancer" ], "interventions": [ { "name": "Nabiximols", "type": "DRUG" }, { "name": "Placebo (GA-0034)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GW Pharmaceuticals Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 397, "start_date": "2010-11-25", "completion_date": "2015-07-02", "has_results": true, "last_update_posted_date": "2018-04-23", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 25, "location_summary": "Phoenix, Arizona • El Cajon, California • Gilroy, California + 19 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "El Cajon", "state": "California" }, { "city": "Gilroy", "state": "California" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01262651" }, { "nct_id": "NCT05269628", "title": "Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis", "Sleep", "Pain" ], "interventions": [ { "name": "Cannabidiol (CBD)", "type": "DRUG" }, { "name": "Tetrahydrocannabinol (THC)", "type": "DRUG" }, { "name": "Placebo CBD", "type": "DRUG" }, { "name": "Placebo THC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tiffany J. Braley, MD, MS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 166, "start_date": "2022-03-25", "completion_date": "2027-08-30", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05269628" }, { "nct_id": "NCT03398083", "title": "Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cannabis Use Disorder" ], "interventions": [ { "name": "THC", "type": "DRUG" }, { "name": "Alprazolam", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" }, { "name": "CBD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute on Drug Abuse (NIDA)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 42, "start_date": "2017-12-04", "completion_date": "2018-05-30", "has_results": false, "last_update_posted_date": "2018-06-14", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03398083" }, { "nct_id": "NCT00624715", "title": "Cannabinoid Receptor Function & Alcoholism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alcoholism" ], "interventions": [ { "name": "THC", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 29, "start_date": "2007-08-09", "completion_date": "2010-06-22", "has_results": false, "last_update_posted_date": "2022-03-11", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 1, "location_summary": "West Haven, Connecticut", "locations": [ { "city": "West Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624715" }, { "nct_id": "NCT04280289", "title": "CBD Cannabis Extract: Pharmacokinetic Studies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "cannabidiol extract", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Mississippi, Oxford", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "21 Years to 55 Years" }, "enrollment_count": 10, "start_date": "2021-02-01", "completion_date": "2021-12-01", "has_results": false, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 1, "location_summary": "University, Mississippi", "locations": [ { "city": "University", "state": "Mississippi" } ], "official_url": "https://clinicaltrials.gov/study/NCT04280289" }, { "nct_id": "NCT01337089", "title": "Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain", "Advanced Cancer" ], "interventions": [ { "name": "Nabiximols", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 660, "start_date": "2011-01-19", "completion_date": "2016-01-27", "has_results": true, "last_update_posted_date": "2023-04-12", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 37, "location_summary": "Phoenix, Arizona • El Cajon, California • Gilroy, California + 31 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "El Cajon", "state": "California" }, { "city": "Gilroy", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01337089" }, { "nct_id": "NCT02608931", "title": "The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nausea", "Vomiting", "Familial Dysautonomia" ], "interventions": [ { "name": "Dronabinol", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 0, "start_date": "2015-11", "completion_date": "2019-03-22", "has_results": false, "last_update_posted_date": "2019-06-13", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02608931" }, { "nct_id": "NCT04992624", "title": "Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee", "Osteoarthritis of the Knee" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Cannabidiol (CBD)", "type": "DRUG" }, { "name": "Tetrahydrocannabinol (Marinol® or generic equivalent (e.g., dronabinol)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Steven E Harte, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "21 Years to 75 Years" }, "enrollment_count": 200, "start_date": "2022-02-22", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-09-30T09:55:46.542Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04992624" } ] }